Optimization of Pharmaceutical R&D Programs and Portfolios

Design and Investment Strategy

Business & Finance, Management & Leadership, Operations Research, Nonfiction, Science & Nature, Mathematics, Applied
Cover of the book Optimization of Pharmaceutical R&D Programs and Portfolios by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319090757
Publisher: Springer International Publishing Publication: October 10, 2014
Imprint: Springer Language: English
Author:
ISBN: 9783319090757
Publisher: Springer International Publishing
Publication: October 10, 2014
Imprint: Springer
Language: English

Very little has been published on optimization of pharmaceutical portfolios. Moreover, most of published literature is coming from the commercial side, where probability of technical success (PoS) is treated as fixed, and not as a consequence of development strategy or design. In this book there is a strong focus on impact of study design on PoS and ultimately on the value of portfolio. Design options that are discussed in different chapters are dose-selection strategies, adaptive design and enrichment. Some development strategies that are discussed are indication sequencing, optimal number of programs and optimal decision criteria.

This book includes chapters written by authors with very broad backgrounds including financial, clinical, statistical, decision sciences, commercial and regulatory. Many authors have long held executive positions and have been involved with decision making at a product or at a portfolio level. As such, it is expected that this book will attract a very broad audience, including decision makers in pharmaceutical R&D, commercial and financial departments. The intended audience also includes portfolio planners and managers, statisticians, decision scientists and clinicians.

Early chapters describe approaches to portfolio optimization from big Pharma and Venture Capital standpoints. They have stronger focus on finances and processes. Later chapters present selected statistical and decision analysis methods for optimizing drug development programs and portfolios. Some methodological chapters are technical; however, with a few exceptions they require a relatively basic knowledge of statistics by a reader.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Very little has been published on optimization of pharmaceutical portfolios. Moreover, most of published literature is coming from the commercial side, where probability of technical success (PoS) is treated as fixed, and not as a consequence of development strategy or design. In this book there is a strong focus on impact of study design on PoS and ultimately on the value of portfolio. Design options that are discussed in different chapters are dose-selection strategies, adaptive design and enrichment. Some development strategies that are discussed are indication sequencing, optimal number of programs and optimal decision criteria.

This book includes chapters written by authors with very broad backgrounds including financial, clinical, statistical, decision sciences, commercial and regulatory. Many authors have long held executive positions and have been involved with decision making at a product or at a portfolio level. As such, it is expected that this book will attract a very broad audience, including decision makers in pharmaceutical R&D, commercial and financial departments. The intended audience also includes portfolio planners and managers, statisticians, decision scientists and clinicians.

Early chapters describe approaches to portfolio optimization from big Pharma and Venture Capital standpoints. They have stronger focus on finances and processes. Later chapters present selected statistical and decision analysis methods for optimizing drug development programs and portfolios. Some methodological chapters are technical; however, with a few exceptions they require a relatively basic knowledge of statistics by a reader.

More books from Springer International Publishing

Cover of the book The Digital Arts and Humanities by
Cover of the book The Paris Agreement by
Cover of the book Creating Social Change Through Creativity by
Cover of the book Correlated Random Systems: Five Different Methods by
Cover of the book Security, Privacy, and Applied Cryptography Engineering by
Cover of the book Developments in Islamic Finance by
Cover of the book Experts and Consensus in Social Science by
Cover of the book Treatment of Pulmonary Hypertension by
Cover of the book Dynamics of Civil Structures, Volume 2 by
Cover of the book Several Real Variables by
Cover of the book Frontiers in Gynecological Endocrinology by
Cover of the book Wind Turbines in Cold Climates by
Cover of the book Competition Law Compliance Programmes by
Cover of the book Bioethical Insights into Values and Policy by
Cover of the book Surgical Endocrinopathies by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy